| Dr Vallee Augustus Debellevue Ii, OD | |
|
72004 Kustenmacher Rd, Abita Springs, LA 70420-3504 | |
| (985) 867-9880 | |
| (985) 867-9880 |
| Full Name | Dr Vallee Augustus Debellevue Ii |
|---|---|
| Gender | Male |
| Speciality | Optometrist |
| Location | 72004 Kustenmacher Rd, Abita Springs, Louisiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144459272 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 727390T (Louisiana) | Primary |
| Provider Name | Vision Clinic Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1568651222 PECOS PAC ID: 1850354713 Enrollment ID: O20041111000007 |
News Archive
Novartis announced today that the US Food and Drug Administration has approved an expanded use for Promacta to include children 1 year of age and older with chronic immune thrombocytopenia who have had an insufficient response to corticosteroids, immunoglobulins or splenectomy.
Inovio Pharmaceuticals, Inc. announced today that Dr. Niranjan Sardesai, COO, will participate on a panel of senior vaccine experts at the 2012 BIO International Convention,the largest global event for the biotechnology industry. Dr. J. Joseph Kim, President and CEO, will present an overview of the company at the Marcum Microcap Conference, which is designed for investors interested in micro-cap companies.
Thousands of people worldwide suffer severe spinal cord injuries each year, but little is known about why these injuries often continue to deteriorate long after the initial damage occurs.
On Wednesday, March 10 and Thursday, March 11, the FDA is convening an Advisory Committee meeting on the clinical trial design for long acting beta-2 adrenergic agonists.
New York Times' The Caucus blog: "Conceding his health care overhaul had 'run into a bit of a buzz saw,' President Obama vowed on Friday to keep fighting for legislation that will 'hold the insurance industry accountable and bring more stability and security to folks in our health care system'" (Stolberg, 1/22).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Vallee Augustus Debellevue Ii, OD 72004 Kustenmacher Rd, Abita Springs, LA 70420-3504 Ph: (985) 867-9880 | Dr Vallee Augustus Debellevue Ii, OD 72004 Kustenmacher Rd, Abita Springs, LA 70420-3504 Ph: (985) 867-9880 |
News Archive
Novartis announced today that the US Food and Drug Administration has approved an expanded use for Promacta to include children 1 year of age and older with chronic immune thrombocytopenia who have had an insufficient response to corticosteroids, immunoglobulins or splenectomy.
Inovio Pharmaceuticals, Inc. announced today that Dr. Niranjan Sardesai, COO, will participate on a panel of senior vaccine experts at the 2012 BIO International Convention,the largest global event for the biotechnology industry. Dr. J. Joseph Kim, President and CEO, will present an overview of the company at the Marcum Microcap Conference, which is designed for investors interested in micro-cap companies.
Thousands of people worldwide suffer severe spinal cord injuries each year, but little is known about why these injuries often continue to deteriorate long after the initial damage occurs.
On Wednesday, March 10 and Thursday, March 11, the FDA is convening an Advisory Committee meeting on the clinical trial design for long acting beta-2 adrenergic agonists.
New York Times' The Caucus blog: "Conceding his health care overhaul had 'run into a bit of a buzz saw,' President Obama vowed on Friday to keep fighting for legislation that will 'hold the insurance industry accountable and bring more stability and security to folks in our health care system'" (Stolberg, 1/22).
› Verified 1 days ago